Apuli Maricel sold BBIO
December 8, 2025 · Form 4 insider transaction
Apuli Maricel sold 2,000 shares of BridgeBio Pharma, Inc. at $74.26 per share, a transaction worth $148.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,000
Price
$74.26
Total value
$148.5K
InsiderApuli Maricel
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after130,297
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.